Procarbazine, lomustine and vincristine for recurrent high-grade glioma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Procarbazine, lomustine and vincristine for recurrent high-grade glioma

Published:2017-07-26 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Parasramka Saurabh¹,Talari Goutham¹,Rosenfeld Myrna²,Guo Jing³,Villano John L¹

Affiliation:

1. University of Kentucky College of Medicine; Department of Internal Medicine; 800 Rose Street, CC447 Lexington Kentucky USA 40536

2. Hospital Clinic /IDIBAPS; Department of Neurology; Villarroel, 170 Barcelona Catalunya Spain 08036

3. Kentucky Clinic; Center for Health Services Research; 740 South Limestone Lexington USA 40536-0284

Publisher

Wiley

Subject

Pharmacology (medical)

Reference46 articles.

1. Boiardi A Silvani A Milanesi I Broggi G Fariselli L Efficacy of '8-drugs-in-one-day' combination in treatment of recurrent GBM patients Journal of Neuro-Oncology 1992 153 8

2. Brada M Stenning S Gabe R Thompson LC Levy D Rampling R Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma Journal of Clinical Oncology 2010 4601 8

3. Pseudoprogression after treatment with the TGF-beta 2 inhibitor trabedersen in high-grade glioma patients;Bogdahn;Journal of Clinical Oncology,2010

4. Efficacy of intratumoral delivery of mitoxantrone in recurrent malignant glial tumours;Boiardi;Journal of Neuro-Oncology,2001

5. Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma;Bower;Cancer Chemotherapy and Pharmacology,1997

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High costs, low quality of life, reduced survival, and room for improving treatment: an analysis of burden and unmet needs in glioma;Frontiers in Oncology;2024-03-20

2. Multitarget Potential Drug Candidates for High-Grade Gliomas Identified by Multiple Reaction Monitoring Coupled with In Silico Drug Repurposing;OMICS: A Journal of Integrative Biology;2024-02-01

3. Base on the Cancer Genome Atlas prognostic for grade II and III glioma;Proceedings of the International Conference on Computer Vision and Deep Learning;2024-01-19

4. Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy;Frontiers in Immunology;2024-01-11

5. Targeting Histone 3 Variants Epigenetic Landscape and Inhibitory Immune Checkpoints: An Option for Paediatric Brain Tumours Therapy;Current Neuropharmacology;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3